Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
170.81+10.94 (+6.84%)
At close: 4:00PM EDT
| Previous close | 159.87 |
| Open | 158.68 |
| Bid | 170.60 x 800 |
| Ask | 170.69 x 1200 |
| Day's range | 158.21 - 171.92 |
| 52-week range | 43.11 - 189.26 |
| Volume | 19,044,899 |
| Avg. volume | 10,999,267 |
| Market cap | 68.414B |
| Beta (5Y monthly) | 1.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.96 |
| Earnings date | 05 May 2021 - 10 May 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 175.58 |
- Yahoo Finance UK
Moderna cuts UK COVID vaccine deliveries as pregnant women told mRNA jabs are safe
The Moderna jab, which works in a similar way to the Pfizer vaccine, uses synthetic messenger RNA (mRNA) technology that can be quickly tweaked to address new mutations of a virus.
- Motley Fool
Why Moderna Stock Climbed Today
What happened Shares of Moderna (NASDAQ: MRNA) rose 6.8% on Friday, as analysts and investors grew more optimistic about the vaccine maker's growth prospects. So what Piper Sandler analyst Edward Tenthoff repeated his overweight rating on Moderna's stock and boosted his price forecast from $208 to $234 on Thursday.
- Yahoo Finance Video
'You can think of it like an annual flu shot': Doctor on possible COVID-19 booster shots
Assistant Professor of Emergency Medicine at Baylor College of Medicine, Dr. Sara Andrabi, joined Yahoo Finance to break down her thoughts on the possibility of needing annual COVID-19 booster shots to.
© 2021 Verizon Media. All rights reserved.
